Trader Alert: Unusual Volume Spotted in Lantheus Holdings, Inc. (NASDAQ:LNTH)

Cornelia Mascio
Febbraio 23, 2017

(LNTH) on Tuesday reported fourth-quarter profit of $4.9 million. O Shaughnessy Asset Management LLC now owns 19,463 shares of the company's stock valued at $167,000 after buying an additional 13,359 shares in the last quarter.

A number of other hedge funds have also bought and sold shares of the company. Bank of New York Mellon Corp increased its stake in Lantheus Holdings by 45.1% in the third quarter. During the same quarter in the previous year, the company posted $0.13 earnings per share.

The biggest institutional shareholders in Lantheus Holdings, Inc. include Avista Capital Partners GP LLC which owns 18 million shares in the company valued at $60.14 million.

08/29/2016 - Lantheus Holdings, Inc. had its " rating reiterated by analysts at Jefferies. Federated Investors Inc. PA now owns 100,284 shares of the company's stock valued at $862,000 after buying an additional 5,660 shares in the last quarter. Tracking the stock price relative to moving averages and highs and lows for the year may help evaluate the future value of the stock. The company has a market capitalization of $296.51 million, a P/E ratio of 9.89 and a beta of 0.29.

Lantheus Holdings Inc opened for trading at $9.05 and hit $9.5 on the upside on Friday, eventually ending the session at $9.45, with a gain of 4.42% or 0.4 points. Lantheus Holdings, Inc. (NASDAQ:LNTH) has risen 47.57% over the past 6 months and is uptrending. The company posted revenue of $74.35 million in the period, compared to analysts expectations of $70.78 million. (NASDAQ:LNTH) shares are now trading $0.44 off the 50-day moving average of $8.91 and $0.68 off of the 200-day moving average of $8.67. The firm's revenue was up 4.4% compared to the same quarter a year ago. During the same period in the prior year, the firm earned $0.13 EPS.

Taking a brief view of stock performance, we see that Lantheus Holdings, Inc. The legal version of this piece can be read at (NASDAQ:LNTH) during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). Credit Suisse Group reissued a "hold" rating and issued a $9.00 price target on shares of Lantheus Holdings in a research note on Thursday, November 3rd. Zacks Investment Research downgraded Lantheus Holdings from a "buy" rating to a "hold" rating in a report on Saturday, October 29th. RBC Capital Markets lifted their target price on Lantheus Holdings from $6.00 to $12.00 and gave the stock an "outperform" rating in a report on Tuesday, November 8th. The company now has a consensus rating of "Buy" and a consensus target price of $9.96.

Lantheus Medical Imaging (NSDQ:LNTH) said today that it signed the term sheet for a deal with GE Healthcare (NYSE:GE) for the development and commercialization of a positron emission tomography myocardial perfusion imaging agent used to improve the diagnosis of coronary artery disease.

Altre relazioniGrafFiotech

Discuti questo articolo

Segui i nostri GIORNALE